Brief: BRAIN Biotech Demonstrates Successful Genome Editing Activity In Mammalian Cells

BRAIN Biotech AG

04/04/2022 09:36

April 4 (Reuters) - BRAIN BIOTECH AG  BNNn.DE :
    * SUCCESSFUL GENOME EDITING ACTIVITY IN MAMMALIAN CELLS WITH
BRAIN-METAGENOME-CAS (BMC), BRAIN-ENGINEERED-CAS (BEC)
    * COMPANY WILL CONTINUE TO DEVELOP THIS TECHNOLOGY JOINTLY
WITH
PARTNERS FOR A MAGNITUDE OF END MARKETS AND APPLICATIONS
    * HAS ACHIEVED A MAJOR MILESTONE SUCCESSFULLY DEMONSTRATING
GENOME
EDITING ACTIVITY IN MAMMALIAN CELL LINES WITH ITS PROPRIETARY
CRISPR-CAS GENOME EDITING NUCLEASES BRAIN-METAGENOME-CAS (BMC),
BRAIN-ENGINEERED-CAS (BEC)

Source text for Eikon:  ID:nEQ79QsDVa 
Further company coverage:  BNNn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))